KRAS-variant

What You Need to Know About Estrogen and the KRAS-variant

Posted by on Oct 2, 2017 in estrogen, founder, KRAS-variant, menopause, Research

What You Need to Know About Estrogen and the KRAS-variant

Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Weidhaas and her team of researchers began exploring the connection between estrogen and breast cancer risk, particularly as it pertains to individuals who test positive for the KRAS-variant.

Read More »